NCT04266639View on ClinicalTrials.gov

Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Stroke, AcuteIschemic StrokeCerebrovascular DisordersCentral Nervous System Diseases
Interventions
DEVICE

Remote Ischemic Conditioning

RIC is commonly achieved by inflation of a blood pressure cuff to induce 5-minute cycles of limb ischemia alternating with 5 minutes of reperfusion

DEVICE

Sham Remote Ischemic Conditioning

Sham Comparator (Sham-RIC)

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

Grethe Andersen

OTHER

NCT04266639 - Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter